[131I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologies
dc.contributor.author | Rachh, S. H. | |
dc.contributor.author | Abhyankar, S. | |
dc.contributor.author | Basu, Sandip | |
dc.date.accessioned | 2012-03-14T05:14:46Z | |
dc.date.available | 2012-03-14T05:14:46Z | |
dc.date.issued | 2011 | |
dc.format.extent | 5478 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Nuclear Medicine Communications, 2011. Vol. 32 (12): pp. 1201-1210 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/5870 | |
dc.language.iso | en | en |
dc.subject | [131I]metaiodobenzylguanidine (MIBG) | en |
dc.subject | neural crest tumors | en |
dc.subject | neuroblastoma | en |
dc.subject | paraganglioma | en |
dc.subject | pheochromocytoma | en |
dc.subject | therapy | en |
dc.title | [131I]Metaiodobenzylguanidine therapy in neural crest tumors: varying outcome in different histopathologies | en |
dc.type | Article | en |